Published 11 days ago • loading... • Updated 11 days ago

Latent Labs emerges from stealth to accelerate drug discovery

Latent Labs, co-founded by Simon Kohl, has emerged from stealth with $50 million in funding to advance drug discovery using AI technology.
The startup focuses on making biology programmable, enabling researchers to create new therapeutic molecules and proteins without relying on wet labs.
The funding round was co-led by Radical Ventures and Sofinnova Partners, with notable angel investors participating.
Latent Labs aims to improve drug development timelines and clinical success rates by using AI to design stable proteins.

Insights by Ground AI

Does this summary seem wrong?

8 Articles

All

Left

Center

Right

Silicon Republic

Latent Labs emerges from stealth to accelerate drug discovery

Latent Labs pushes the frontiers of generative biology, CEO Simon Kohl said. Read more: Latent Labs emerges from stealth to accelerate drug discovery

11 days ago

Read Full Article

TechCrunch

Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

11 days ago·United States

Read Full Article

Verdict

AI startup Latent Labs launches with $50m funding

AI startup Latent Labs has announced its launch, raising a total of $50m in funding to advance the development of AI models for programmable biology. Founded by Dr Simon Kohl, a former DeepMind researcher, the company co-headquartered in London and San Francisco aims to accelerate progress and partnerships in AI-powered programmable biology. The funding comprises $40m raised in a Series A financing round, which was jointly led by Radical Venture…

11 days ago

Read Full Article

Pharmaphorum

Ex-DeepMind scientist launches drug discovery company

Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform

11 days ago

Read Full Article

BusinessCloud.co.uk

DeepMind figure launches AI MedTech with £40m funding

An AI MedTech company has launched from ‘stealth’ after securing £40m in funding. Headquartered in both London and San Francisco, Latent Labs is building AI foundation models to make biology ‘programmable’. The company was founded by Dr Simon Kohl, previously a co-lead of DeepMind’s protein design team and a senior research scientist on DeepMind’s AlphaFold2, the project which earned a Nobel Prize for Chemistry for Demis Hassabis and John Jumper…

11 days ago

Read Full Article

FinSMEs

Latent Labs Raises $50M in Funding

Latent Labs, a London, UK-based company building AI foundation models to make biology programmable, raised $50M in total funding. The round was led by Radical Ventures and Sofinnova Partners, with the participation of Flying Fish, Isomer, as well as existing investors 8VC, Kindred Capital and Pillar VC, and angels including Jeff Dean, Aidan Gomez, and […] The post Latent Labs Raises $50M in Funding appeared first on FinSMEs.

11 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year